← SynDRA
acarbose
SynDRA canonical compound SYN0041727 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | MGAM |
|---|
| Mechanism of action | Glucosidase inhibitor |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
- MGAM
- AMY2A
- GAA
- AMY1A
- AMY2
- Gaa
- IMA1
- SI
- Si
Mechanisms of action (all sources)
- Glucosidase inhibitor
- MGAM MODULATOR
- MGAM INHIBITOR
- AMY2A INHIBITOR
Drug classes
- alpha Glucosidase Inhibitors
- alpha-Glucosidase Inhibitor
- Enzyme Inhibitors
- Glycoside Hydrolase Inhibitors
- Hypoglycemic Agents
ATC classes
- BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- ascarbose
- glucobay
- prandase
- precose
- Acarbosa
- BAY-G-5421
- NSC-758915
- Glucobay
- Precose
- Prandase
- C25H43NO18
- CHEBI:2376
- CHEMBL3734896
- BAY-g 5421
- 4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucopyranose
- SMR000466376
- SR-01000759407
- Acarbose/
- Acarbose [USAN:BAN:INN:JAN]
- Acarbose,(S)
- Precose (TN)
- AC1L26GM
- Acarbose (JAN/USAN/INN)
- MLS006011898
- MLS000759506
- MLS001424056
- SPECTRUM1505172
- SCHEMBL5316305
- CHEMBL404271
- BDBM23406
- MolPort-002-507-369
- RefChem:934832
- Glucobay;
- Precose;
- MFCD00869592
- Acarbose hydrate
- Prandase;
- Acarbose CRS
Look up acarbose in the interactive SynDRA portal →